Current Ratio of AEON Biopharma, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
AEON Biopharma, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • AEON Biopharma, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 79%, a 161% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

AEON Biopharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 79% +49% +161% 30 Sep 2025
Q2 2025 62% +7% +13% 30 Jun 2025
Q1 2025 46% -4% -7.2% 31 Mar 2025
Q4 2024 20% -37% -64% 31 Dec 2024
Q3 2024 30% +5% +21% 30 Sep 2024
Q2 2024 55% +44% +393% 30 Jun 2024
Q1 2024 50% +38% +319% 31 Mar 2024
Q4 2023 57% +44% +354% 31 Dec 2023
Q3 2023 25% -20% -45% 30 Sep 2023
Q2 2023 11% -82% -88% 30 Jun 2023
Q1 2023 12% -171% -94% 31 Mar 2023
Q4 2022 13% -298% -96% 31 Dec 2022
Q3 2022 45% -438% -91% 30 Sep 2022
Q2 2022 93% 30 Jun 2022
Q1 2022 183% 31 Mar 2022
Q4 2021 311% 31 Dec 2021
Q3 2021 483% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.